Mandeg, Anacel M.
HRN: 06-08-05 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/13/2022
CEFUROXIME 1.5GM (VIAL)
11/13/2022
11/20/2022
IV
1.5 Gms
On Call To OR
For Scheduled Curettage
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes